Skip to main content

Table 1 Patient demographic and clinical data

From: Ex vivo localization and immunohistochemical detection of sentinel lymph node micrometastasis in patients with colorectal cancer can upgrade tumor staging

Variables

Statistics

Age (y)

57.00 ± 13.82

Lymph node ratio

0.05 ± 0.10

Survival duration (months)

61.69 ± 17.20

DFS duration (month)

56.33 ± 23.38

Gender

 

 Male

32 (59.3)

 Female

22 (40.7)

Location of tumor

 

 Colon

28 (51.9)

 Rectum

26 (48.1)

Depth of invasion

 

 T1

2 (3.7)

 T2

8 (14.8)

 T3

21 (38.9)

 T4

23 (42.6)

Stage

 

 I

7 (13.0)

 II

25 (46.3)

III

22 (40.7)

Death

13 (24.1)

Recurrence or metastasis

14 (25.9)

  1. DFS, disease free survival; HE, hematoxylin-eosin; SLN, sentinel lymph node.
  2. Continuous variables were shown as mean ± standard deviation and categorical variables were presented as number (%).
Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us